Patient Support and Advocacy

Patient Support and Advocacy

Patient support programs have become a standard business practice to ensure patient access, however, life sciences, medical device and pharmaceutical companies must be cautious as regulatory scrutiny increases.

It is increasingly important that companies adopt proactive strategies to engage with patients and caregivers, and support them throughout the treatment journey. As a result, industry is partnering with independent patient advocacy organizations and providing financial support to raise awareness and improve patient outcomes.

    The high cost of novel therapies is often due to small patient populations from which companies must recoup large research and development investments and the considerable cost of education and adherence support often necessary to support innovative treatments. These costs often present significant barriers to entry that must be resolved for a product to be commercially viable.